Mucin polymers and mucopolysaccharide network (MUC)

Mucin polymers and the associated mucopolysaccharide network are the fundamental structural elements of the mucus gel that protects epithelial surfaces in the respiratory, gastrointestinal, and urogenital tracts. These networks are primarily composed of large, secreted gel-forming mucins, such as MUC5AC and MUC5B, which are heavily O-glycosylated and cross-linked via disulfide bonds to form a complex, viscoelastic matrix (UniProt P35226, P98088). The primary biological role of this network is to act as a selective physical barrier that traps pathogens and particulates while facilitating their removal through mucociliary clearance (Annual Review of Physiology, 2018). In pathological conditions like cystic fibrosis and chronic obstructive pulmonary disease (COPD), the network becomes hyper-concentrated and excessively cross-linked, leading to stagnant, thick mucus that obstructs airways and promotes chronic infection (NEJM, 2018). Pharmacological targeting of this network involves mucolytic agents that chemically reduce disulfide bonds to decrease viscosity, or agents like dornase alfa that degrade extracellular DNA trapped within the mucopolysaccharide matrix (StatPearls, 2023; FDA Label). Understanding the biochemical properties of these polymers is crucial for developing therapies that restore normal mucus rheology and improve patient outcomes in obstructive lung diseases.

Other names

Mucus gelMucin glycoproteinsGlycosaminoglycan networkMucus barrierMucopolysaccharides

Reduction of disulfide bonds, enzymatic cleavage of extracellular DNA, stimulation of mucociliary clearance, and inhibition of mucin hypersecretion.